Dechra Pharmaceuticals is a drugs company that specialises in the development of medical treatments for pets. Over the next three years, the firm’s earnings per share is expected to more than double.
Recent articles Shire PLC
Ailsa Craig picks three stocks that should capitalise on the M&A trend in the pharmaceutical sector, either as potential targets or as well-established acquirers of other rivals.
The ageing population is an opportunity for the health and medical sector. Here, professional investor Garry White picks three healthcare stocks to buy now.
Pharma giant Shire has made an unsolicited $30bn all-share offer for America’s Baxalta.
Investors have shrugged off concerns over the falling price of oil this morning ahead of the release of US earnings data.
The US government has issued new rules making it harder for American companies to cut their tax bill by relocating their headquarters.
US pharmaceuticals group AbbVie has made a fourth attempt to bag London-listed Shire Pharmaceuticals.
More and more American businesses are snapping up companies in low-tax countries to make that their official home. British companies are in their sights. Simon Wilson reports.